JULIET®TI TL is a titanium interbody implant featuring the company’s proprietary Ti-LifeTechnology.Ti-LifeTechnology micro-porous scaffold is designed to mimic the bone trabecular structure, featuring interconnected pores of 600μm to 700μm and an overall porosity of 70-75%—intended to enable cell colonisation and promote bone in-growth.The Juliet Ti PO, OL and TL interbody systems include a range of sizes to address different anatomies. The bullet-shaped nose, lateral sides and chamfers of the implant are polished, intending to preserve endplates, nerve roots and soft tissues during insertion.The Juliet Ti design also features an overall reduced density to optimise the imaging performances.
Benefits:
- TI-LIFE TECHNOLOGY:The osteoconductive structure mimics the bone trabecular geometry and is designed to promote bone in-growth.
- IMAGING PERFORMANCE:The JULIET®Ti design features an overall reduced density to optimize the imaging performances.
- EASY INSERTION:All our cages feature a smooth bullet self-distracting nose. This design allows an easy insertion, enabling a distraction of the intervertebral space.
- MULTI AXIAL IMPLANT HOLDER:The implant holder locking mechanism allows to change the direction of the device during implantation ensuring a precise anterior positioning of the cage in situ.
About TLIF
A transforaminal lumbar interbody fusion (TLIF) is performed to remove a portion of a disc that is the source of back or leg pain. Bone graft is used to fuse the spinal vertebrae after the disc is removed. TLIF provides fusion of the front and back of the lumbar spine. The front portion of the spine, called the anterior column, is stabilized by the interbody spacer and bone graft. The back portion, or posterior column, is locked in place with pedicle screws, rods and additional bone graft, alongside the backs of the vertebra.
About Spineart
Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients. The company was established in 2005 and is currently operating in 46 countries worldwide.Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment.Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.Please visit:http://www.spineart.com